Preexisting Autoantibodies and Immune Related Adverse Events in Metastatic Urothelial Carcinoma Patients Treated by Pembrolizumab
- Resource Type
- Article
- Source
- In
Clinical Genitourinary Cancer October 2022 20(5):e362-e368 - Subject
- Language
- ISSN
- 1558-7673